An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism

BACKGROUND: Calcimimetics have been shown to be effective and safe therapies for the treatment of secondary hyperparathyroidism (sHPT), a serious complication of disordered mineral metabolism associated with dialysis-dependent chronic kidney disease. Etelcalcetide, a recently approved intravenous ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Block, Geoffrey A., Chertow, Glenn M., Sullivan, John T., Deng, Hongjie, Mather, Omar, Tomlin, Holly, Serenko, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420005/
https://www.ncbi.nlm.nih.gov/pubmed/30875390
http://dx.doi.org/10.1371/journal.pone.0213774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420005/
https://www.ncbi.nlm.nih.gov/pubmed/30875390
http://dx.doi.org/10.1371/journal.pone.0213774

Ejemplares similares